Caribou Biosciences Inc. (CRBU)
1.55
-0.01 (-0.64%)
At close: Jan 15, 2025, 12:42 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 34.48M | 13.85M | 9.60M | 12.36M | 5.79M |
| Cost of Revenue | 112.08M | 3.64M | 984.00K | 34.42M | 23.64M |
| Gross Profit | -77.60M | 10.21M | 8.61M | -22.06M | -17.85M |
| Operating Income | -116.06M | -106.40M | -66.98M | -36.12M | -34.30M |
| Interest Income | 10.70M | 4.60M | 148.00K | 236.00K | 1.05M |
| Pretax Income | -101.88M | -99.35M | -66.60M | -36.13M | -30.97M |
| Net Income | -102.07M | -99.42M | -66.92M | -34.31M | -23.43M |
| Selling & General & Admin | 38.46M | 38.02M | 24.32M | 14.06M | 16.46M |
| Research & Development | 112.08M | 82.23M | 52.26M | 34.42M | 23.64M |
| Other Expenses | n/a | 7.18M | -1.35M | 514.00K | n/a |
| Operating Expenses | 150.54M | 120.25M | 76.58M | 48.48M | 40.09M |
| Interest Expense | n/a | n/a | 8.00K | 20.00K | 4.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 150.54M | 120.25M | 76.58M | 48.48M | 40.09M |
| Income Tax | 193.00K | 70.00K | 321.00K | -1.82M | -7.54M |
| Shares Outstanding (Basic) | 73.81M | 60.80M | 60.26M | 59.97M | 59.97M |
| Shares Outstanding (Diluted) | 73.81M | 60.80M | 60.26M | 59.97M | 59.97M |
| EPS (Basic) | -1.38 | -1.64 | -1.11 | -0.57 | -0.39 |
| EPS (Diluted) | -1.38 | -1.64 | -1.11 | -0.57 | -0.39 |
| EBITDA | -112.53M | -104.78M | -66.00M | -35.21M | -30.21M |
| Depreciation & Amortization | 3.52M | 3.64M | 984.00K | 900.00K | 751.00K |